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Some of the physiological properties of the
cerebral circulation, intracranial pressure and brain
metabolism, as well as some of the pathophysiological alterations that we see with various
types of brain injuries have been discussed in this series. We are going to see how we can apply some of
this information clinically. I will begin with a patient.
A patient, comatose following a severe head injury, is brought into the emergency room. Our
method of managing these patients has evolved over
a number of years. Although I shall present the
procedure to you sequentially, in fact, much is done
virtually simultaneously. As always, the first thing
that one must attend to is the airway. The majority of
comatose head-injured patients, upon admission to
the emergency ward, have a hyperventilation syndrome. It is of primary necessity, in this situation, to
obtain an arterial blood sample for measurement of
Pa 0 , Paco, and pH. Frequently, the patient is
hypocapni~, with a Paco, of perhaps 30, and is hypoxic as well. In a large series from several clinical units,
the average Pa 0 , of several hundred patients at the
time of admission was about 65-70 mm Hgsomewhat hypoxic but generally not severely so.
How can the patient be hyperventilating, be
hypocapnic, and hypoxic at the same time? Nearly all
of these patients have some degree of pulmonary
arteriovenous shunting but are able to eliminate the
C0 2 with their relatively inadequate respirations,
because C0 2 diffuses across the alveolar membrane at
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twenty times the rate of oxygen. At the same time,
they are not able to get enough 0 2 into the blood .
Hypoxia and hypocapnia are a very common
pulmonary syndrome in these patients.
if the patient looks as though he is severely brain
injured and is not going to recover soon, we go straight
to intubation after drawing the arterial blood gas .
The patient's airway is cleaned and he is then ventilated with an Ambu® bag. By now, someone is taking
the blood pressure and the heart rate. If the patient
has a mass lesion, then, in a majority of cases, he has
a so-called Cushing response consisting of arterial
hypertension. He may or may not have bradycardia;
in fact, in our experience, in the acute brain injured
patient; tachycardia is more common than bradycardia, except in those patients with acute extradural
hematomas. A decision must be made now as to how
to manage the patient over the next hour. We give
dexamethasone (IO mg IV), although I am not at all
convinced that the patients are benefitted by it. If the
patient is in extremis, we give 1.5 mg/kg of hypertonic mannitol by IV push, in the hope of buying time
for angiography. We like to have angiography for all
of these patients as soon as possible. It must be
remembered, however, that if done within an hour or
two of the injury, one may miss the hematoma that is
in the process of developing. If the neurosurgeon in
charge feels that there is not time for an angiogram,
the surgeon may perform exploratory burr holes. We
avoid this operation if possible, since we feel that
angiography gives so much information. (The
technique mentioned in Dr. Vries' presentation of inserting a ventricular cannula, injecting some air, and
then treating the patient immediately, depending
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upon what that air study shows is impressive; if the
patient has a shift, take him directly to the operating
room.) If the patient does not have a mass lesion, a
Scott cannula is placed through a twist drill hole into
the anterior horn of the right lateral ventricle, in
order to measure intracranial pressure continuously.
If the patient goes to the operating room and has a
mass lesion removed, the Scott cannula is put into the
anterior horn of the lateral ventricle at the time of
surgery.
The patient is then returned to the neurosurgical
intensive care unit, where we go through a number of
procedures which will constitute the bulk of my discussion. Figure 1 is simply an artist's sketch of the
Scott cannula in the anterior horn of the right lateral
ventricle at the level of the coronal suture. Again,
Figure 2 is an artist's sketch of the patient in the intensive care unit with the head dressing and the Scott
cannula. The transducer is wrapped in a sterile towel
because there is a risk of infection from an insideo utsi de connection of CSF, and this requires
meticulous technique. In 350 cases, we have had an
infection rate of about 2%, which compares favorably
with Lundberg's 1.6% infection rate in something
Fig. 2

Fig. I

over 1,000 patients with continuous recording of intracranial pressure. We would like to get rid of the intra ventricular cannula, because we consider 2% to be
still too high, but we do not feel, at this time, that
there is an adequate solid state transducer for
measuring intracranial pressure.
Figure 2 also shows a two channel strip chart
recorder. One channel records the intracranial
pressure and the other, systemic arterial pressure
from a catheter in either the radial or the brachia!
artery.
At this point, we prepare to do regional cerebral
blood flow and metabolism studies. We use the 133Xe
clearance technique, in order to measure regional
cerebral blood flow (RCBF). Xenon is injected
through a catheter placed under fluoroscopic control
into the internal carotid artery and the xenon is then
injected as a bolus. The xenon enters the brain,
diffuses into the brain tissue, and is then cleared from
the tissue over a period of about 15 minutes. The rate
of clearance from each region under study determines
the blood flow; therefore, the faster the rate of
clearance, the faster the flow. There are a number of
ways of examining and analyzing these clearance
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curves. We feel, for our purposes, that eight probes
for measuring RCBF over each hemisphere are perfectly adequate. There are, however, extremely
sophisticated systems in which it is possible to
measure the RCBF from as many as 250 regions.
In addition, a second catheter is placed percutaneously into the jugular vein and passed well up
into the intracranial space, into the sigmoid sinus, in
order to obtain a cerebral venous blood sample.
Periodically during the course of the clinical investigation, simultaneous samples of blood are taken
from the artery (from the internal carotid artery, in
this case) and from the jugular bulb, from which it is
possible to calculate the cerebral metabolic rate of
oxygen (CMR 0 ). Studies on the cerebral metabolic
rate of glucose, 'lactate, and pyruvate have been done
as well. In fact, if one's techniques are sophisticated
enough, accurate enough, in theory at least, it is possible to measure anything that the brain utilizes 1:Jy
measuring the content in both the arterial blood and
the cerebral venous blood. Here we shall discuss only
CM Ro,, oxygen utilization . First, we determine the
0 2 content in both the arterial and venous samples;
CM R 0 is equal to the arteriovenous difference of
oxygen' content times the mean cerebral blood flow
divided by 100.
Table I shows a selection of the normal values,
such as CBF, approximately 50 ml/100 gm/ min,
systemic arterial pressure, about 85 . We defined, as
have others, normal intracranial pressure as less than
200 mm CSF or less than 15 mm Hg. The cerebral
perfusion pressure, assuming an ICP of 10, is 75 mm
Hg, the normal arterial-venous oxygen difference
(A YD 0 ) is 7-a figure to remember. The CMR 0 is
3.5 ml / 100 gm/ min and the normal values for arte;ial
blood gases and pH are familiar to you.
For the sake of example, a single patient will
now be described in detail.
A SO-year-old man had been found on the street
and was brought into the emergency ward comatose;
he had bruises about the head, indicating that he had
been bludgeoned, and there were clinical signs pointing to a left hemispheric mass with evidence of
transtentorial herniation. He was given dexamethasone and mannitol and was intubated and ventilated with the Ambu® bag. The resident who was
caring for him felt that he was in extremis, that there
was not enough time to do an angiogram, despite the
administration of mannitol; therefore, the patient
was taken to the operating room for burr holes .
There was no evidence of an extracerebral
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TABLE I

Normal values of variables tested

Variable
cerebral blood flow (CBF)
systemic arterial pressure (SAP)
intracranial pressure (ICP)
cerebral perfusion pressure (CPP)
cerebral vascular resistance (CYR)
arteriovenous blood oxygen content
(AYDO,)
cerebral metabolic rate (CMRC,)
arterial carbon dioxide partial
pressure (PaCO,)
arterial oxygen partial pressure
(PaO,)
arterial blood acidity (pH)

Normal Value
50 ml/100 gm / min
85 mm Hg
15mmHg(200
mm CSF)
75 mm Hg
1.70
7.0 vol %
3.5 ml/ I 00 gm / min
40mm Hg
IOOmm Hg
7.35

(Reproduced by permission of the American Association of
Neurological Surgeons , and the authors, from D. A. Bruce, et al,
"Physiological Changes in Brain During Coma," J Neurosurg
38:133, 1973.)

hematoma; the resident needled the brain one time
and got no blood, and the Scott cannula was put in
along with a solid state transducer to measure intracranial pressure. The patient was then taken to the
angiography suite, where we also do the RCBF and
metabolism studies. On angiogram, the patient had a
huge, temporal and deep mass in the hemisphere. The
Scott cannula was, in this case, placed through a burr
hole in the lateral ventricle. While the angiogram was
being developed, we carried out our first RCBF and
metabolism study.
Figure 3 demonstrates one of the ways in which
we display the data. You will note that this patient,
during the control period, had a mean CBF of 10
ml / 100 gm/ min, one-fifth normal and far below that
ordinarily required to maintain brain function. The
patient's mean systemic arterial pressure was 135 mm
Hg, and the mean intracranial pressure extremely
high at 107 mm Hg, giving the patient then a cerebral
perfusion pressure (CPP) of 28. Note that at this
time, the Pa 0 is quite adequate at I 04 and the Paco is
slightly low. The value for CMR 0 -0.71-is one-fifth
normal. One can state as a gener~I rule, with the occasional rare exception, that any patient with CM Ro,
less than 1.0 probably will not survive.
The angiogram showed the huge mass which had
been missed in the operating room with the single
pass of the needle. The needle was then inserted into
the region of the mass and we obtained 70 cc of
blood. A second postevacuation study was per-

170

LANGFITT: PATIENTS WITH SEVERE HEAD INJURY

because of the edema, we now saw his Pa0 dropping
also, from 104 to 75.
'
Despite the improvement in the CBF and some
evidence of clinical improvement, the patient's
CMRo actually fell from 0.71 to 0.39, which is barely
one-te~th of normal. We tried to raise his blood
pressure, hoping to improve his perfusion pressure
and further improve his CBF, then at 18. Figure 4
shows the response following angiotensin. We
brought his SAP up to 129 from 76, but the CBF increased only from 18 to 23, because, with the arterial
hypertension and the edema fluid , the intracranial
pressure has gone from 47 to 74 mm Hg. In order to
comprehend the pathophysiology of these patients,
one must measure nearly all of these variables.
Despite his marked hypocapnia and hyperventilation, his Pa0 is still only 67 because of his pulmonary
edema. We decided to give mannitol, and the patient,
in terms of CBF, responded dramatically; CBF went
from 23 to 38, perfectly adequate for a normally
metabolizing brain, and ICP dropped from 74 to 48.

Fig. 3

formed, disclosing the reduced mass with the estimated increase in CBF from 10 to 18 ml/100
gm/ min . In the region of the mass, where blood flow
was virtually obliterated, we had a fourfold increase
from 6 to 24 ml/ 100 gm/ min. The intracranial
pressure dropped from 107 to 47 mm Hg following
evacuation of the mass. If we were measuring only
the ICP, we might feel we had really accomplished
something. The systemic arterial pressure, however,
was being held up by a Cushing response, secondary
to the intracranial hypertension . Although we
markedly reduced the intracranial pressure, the blood
pressure fell equally, and the perfusion pressure went
only from 28 to 29; despite that, we did increase CBF
by 8 ml/100 gm/ min.
Now, however, another problem arose. The
patient, comatose but showing slight evidence of
arousal, went from flaccidity to some decerebrate
posturing; he also began to hyperventilate, driving his
Paco from 36 down to 23, but, at the same time, he
developed acute pulmonary edema. Even though he
was hyperventilating and producing hypocapnia,

Fig. 4
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Marked improvement in CBF occurred, despite the
fact that the patient's perfusion pressure dropped
from 55 to 46. A change in flow, of course, will occur
with a change in perfusion pressure or a change in
resistance or with a change in both, and, in this case,
it is quite clear that the mannitol has reduced the
edema, thereby opening up the microcirculation and
permitting a marked improvement in CBF, despite
there being no significant change in the patient's
CPP. The Pa 0 and Paco were the same; the CMR0
was fluctuating somewh~t.
'
We continued to battle his intracranial pressure,
which, however, continued to rise, and finally, as is
the rule in these cases, the intracranial pressure
equaled the blood pressure. At this point, the phenomenon of nonfilling of the cerebral circulation upon
angiography or injection of 133 X became evident. In
this situation, if one injects radio-opaque media into
the carotid artery, it will rise up into the internal
carotid (sometimes to the level of the siphon) and
then stop. A film taken 30 seconds or a minute later
will show the opaque dye still sitting in the carotid
artery, none having entered the intracranial space,
due to the fact that ICP equals SAP and, therefore,
CPP is zero. When this occurred in our patient, we
decided he obviously had all of the clinical criteria of
brain death. We decided, however, to manipulate the
blood pressure with a vasopressor agent, Levophed®,
to see whether we could possibly reestablish a perfusion pressure. These primary changes in systemic
arterial pressure, produced by altering the rate of drip
of a vasopressor agent, produced precisely equal
changes in the ICP. There was no way to reestablish
perfusion pressure by ma nipulating the arterial
pressure. In this patient who had a severe and, as it
turned out, irreversible brain injury, we were, by
various types of manipulations, able to raise his CBF
to something approaching a normal range, but too
late, and the patient died shortly after this study.
Now, just a few comments on intracranial
pressure. Until the publication of Lundberg's landmark monograph from the University of Lund in
Sweden in 1960, we generally thought of ICP as being
a steady phenomenon; intracranial pressure had been
measured only through the lumbar subarachnoid
space in the vast majority of patients. In 1963, we
demonstrated in experimental a nimals (using a slowly
expanding extradural balloon in the monkey), that
when the intracranial pressure rises by virtue of expansion of a mass, a dissociation occurs invariably,
between the supratentorial pressure and the pressure
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of the lumbar subarachnoid space. Finally, with the
slow expansion of the balloon, when the intracranial
pressure reached the level of the blood pressure in the
monkey, lumbar subarachnoid pressure was normal.
We demonstrated that this also occurs in man . The
higher the intracranial pressure, the greater the brain
swelling, the less likely it is that the lumbar subarachnoid pressure will reflect that increased intracranial pressure. Many times in man, lumbar subarachnoid pressure is normal when the intracranial
pressure is from 50-100 mm Hg. It follows, therefore,
that one cannot use lumbar subarachnoid pressure to
determine the actual pressure within the intracranial
space. All pressure measurements today are done
directly from the intracranial space by one method or
another.
Lundberg then demonstrated that in many
patients, intracranial pressure is not a steady
phenomenon; in fact, there are tremendous fluctuations in pressure. He described what he called "A
waves or plateau waves, B waves, and C waves." For
the most part, these waves appear to be rather innocuous, there being, usually, no indication of
neurological deterioration. With the extremely
dangerous plateau wave, the intracranial pressure is
reasonably steady, at first, but then fluctuates, and
finally, inexorably rises-a terminal pressure wave.
Figure 5 summarizes work that we did some 10
or 11 years ago. It is a very simple figure but quite important. This is the volume pressure graph within the
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intracranial space, actually taken from a series of
monkeys. We put in an extradural balloon, and then
slowly inflate it at a rate of 1 ml/min, while we
measure the intracranial pressure. Up to a volume of
about 5 ml in the balloon, there is no significant
change in intracranial pressure. Why is this? Because
the intracranial space contains displaceable fluid,
mainly in the form of CSF but also, to some extent, in
the form of intravascular blood. Since we are dealing
with a cavity that is nondistensible, which is filled to
capacity with a noncompressible fluid and solid
material, it follows that if indeed we had a completely
closed system, that is, if we had a sphere made of
bone filled to capacity with water, and we attempted
to inject additional water into that cavity, we could
probably inject no more than 0.1 ml, in the case of the
monkey; we would get a tremendous rise in intracranial pressure, simply because we cannot stretch
the shell. We cannot compress the fluid. That is not
the case in life. We can actually put 5 ml of fluid into
this monkey's skull (total capacity of 100 ml),
because of spatial compensation. It means that up to
a value of about 5 ml, for every 1 ml that we are putting into the balloon, we are expressing I ml of CSF
or blood. Then we pass from this period of spatial
compensation, the horizontal portion of the volume
pressure graph, onto the vertical portion. Note here
that between a balloon volume of 7 and 8 ml, the intracranial pressure rises 75 mm Hg. Thus, in the case
of those patients with pressure waves, those who have
any kind of mass lesion or brain edema, the bulk of
them are somewhere on the vertical part of the graph.
The pressure waves are due to spontaneous
alterations in cerebral blood volume. The pressure
waves are reflecting alternating vasodilatation and
vasoconstriction of the cerebral vascular bed. We do
not know the reason for this. The vasodilatation
produces a slight increase in cerebral blood volume.
That slight increase, however, when the patient is on
the vertical portion of the volume pressure graph, will
produce a tremendous change in pressure. The
patient who presents with a longstanding spaceoccupying mass, chronic subdural hematoma or
meningioma, who has now reached the limits of his
period of spatial compensation, therefore, may have
few signs or symptoms, but he is sitting on a time
bomb as it were. When he goes to sleep, for example,
he becomes a little hypoxic and hypercapnic. We
recorded many of these patients in sleep, and indeed,
their intracranial pressure may rise astonishingly during sleep, simply because of a little bit of vasoqilata-

tion from the hypercapnia. It follows as well, that if
one is treating a patient who is on the vertical portion
of the curve, it is necessary to remove only a small
portion of any one of the volumes within the intracranial space in order to drop the pressure. We
have many patients who have had pressure of 80-90
mm Hg. The removal of no more than 2 ml from the
ventricle will drop the pressure down to 20-30 mm
Hg, because they are falling on an extremely sharp
vertical portion of the curve.
What constitutes a critical level of intracranial
pressure for brain function? I have no idea, because it
varies so much from patient to patient. The more the
brain itself is damaged, that is, the more the edema,
the more contusion, then the less tolerant that patient
is of intracranial hypertension. We have many
patients, for example, who would not tolerate an ICP
above 25-30 mm Hg; they would obtund, develop a
hemiparesis. When we then lowered the pr~ssure to
10-15 mm Hg, they would improve. Patient~ who do
not have brain damage but, nevertheless, have intracranial hypertension, will often tolerate extremely
high levels of intracranial pressure. We have seen a
young woman with severe hydrocephalus from a
cerebellar hemangioblastoma. She was neurologically
normal, except for minimal ataxia and some
papilledema-her brain was normal. We recorded
her intracranial pressure continuously through the
Scott cannula and then slowly drained the ventricles
over a period of two or three days, as we always do
before doing posterior fossa surgery in these people.
We also recorded and checked the: systemic arterial
pressure from the catheter in the the radial artery.
For very long periods of time, the patient had a CPP
as low as 6 mm Hg, the mean intracranial pressure,
85, and the mean arterial pressure, 91; this particular
time, she was in the intensive care unit, sitting up
reading a magazine, completely asymptomatic. This
is an indication of the phenomenal degree of
autoregulation that can be seen clinically.
If a hypertonic solution such as mannitol has
been given to a patient without causing reduction in
his intracranial hypertension, we might conclude that
mannitol has been of no benefit, and not give it to
that patient again. We might say that the patient is
refractory to mannitol.
Often this is not the case, and the patient improves despite no major ICP fall. How can this be?
We postulate that mannitol has reduced edema.
Reduction of the water content in the brain alone,
obviously, should result in decrease in intracranial
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pressure, but if one has compression of the microcirculation of the capillary bed in the venules by the
edema, and one reduces the edema, what is going to
happen to the cross-sectional area of the vascular
bed? It will enlarge as the compression is relieved.
Our guess is that as we remove the edema from the
brain with the mannitol, the edema is being replaced
by intravascular blood secondary to expansion of the
cerebral vascular bed. The net intracranial volume
remains the same, and intracranial pressure does not
decrease. What these data clearly show is that one
cannot use intracranial pressure alone to determine
whether or not mannitol has had a beneficial effect on
the patient; one must, unfortunately, measure CBF.
The first indication for the use of mannitol
therapy, in our opinion, is for reducing brain bulk
during craniotomy, and second, for reducing ICP to
permit time for emergency cerebral angiography. The
third indication for its use is control of ICP during
continuous recording of /CP. I believe that the intermittent, or perhaps even the continuous, use of mannitol in these patients without continuous recording
of intracranial pressure is very dangerous, because if
the patient has a hemorrhage, a hematoma that is expanding, reduction of the intracranial pressure causes
further expansion of the hematoma; then, as the osmotic gradient is reversed, fluid comes back into a
space reduced by the enlargement of the hematoma.
This kind of situation can kill the patient quickly.
I will conclude by saying that I think the continuous measurement of intracranial pressure in the
proper management of patients not only with severe
head injuries, but with severe brain insults as well,
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has passed now from being a research tool to a virtual
necessity. I cannot say the same thing, yet, about
measurements of RCBF and cerebral metabolism, as
we are now caught in an ethical bind. We have four
or five RCBF runs, or consecutive studies, done on
patients over several hours. Rarely have we been able
to repeat these studies, because we did not feel justified in repuncturing the carotid artery, unless it was
necessary to do an angiogram on the patient. My
contention is that we would learn much more from
one patient with severe brain injury who has ten CBF
studies over a period of several days than we would
learn from ten patients who have one study each. In
order to prove that these techniques, which are expensive and time consuming, are really going to help
us in the management of these patients, we now need
to have a reliable noninvasive technique for doing
RCBF. These techniques are now available, particularly in the form of either inhalation or intravenous injection of 133Xe, but the mathematics are
extremely complex and must be done with a
laboratory computer, but I think they are promising.
In our neurosurgical intensive care unit, we are just
beginning to compare the carotid injection of xenon
with the inhalation of xenon, to see how well the
results correspond in our patients with severe brain
injuries. Ifwe obtain a reliable noninvasive technique
and can repeat the RCBF studies every hour, day and
night for as long as we wish, with no harm whatsoever to the patient, we will then be able to provide
the intensive treatment for these patients and the
evaluation of the therapy to which we have looked
forward for so long.

